
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-11-04-2015
- Volume 11
- Issue 11
FDA Extends Compliance Dates for Drug Dispensers
Citing compliance issues, FDA extends deadline for product tracing information requirements for dispensers to March 1, 2016.
FDA has issued a revised guidance document that extends a previously issued Compliance Policy for the Drug Supply Chain Security Act (DSCSA) from Nov. 1, 2015 to March 1, 2016 because some drug dispensers-primarily smaller, independent pharmacies and health systems-have expressed that they need additional time to work with partners on compliance issues.
The DSCSA requires dispensers, primarily pharmacies, to comply with new requirements related to product tracing beginning July 1, 2015. In a Compliance Policy published on July 6, 2015, FDA stated that the agency did not intend to take action until Nov. 1, 2015 against dispensers that accepted ownership of product without receiving the product tracing information or who did not capture and maintain the product tracing information as required by the law.
The most recent FDA guidance document, DSCSA Implementation: Product Tracing Requirements for Dispensers–Compliance Policy (Revised), issued on Oct. 28, 2015, extends this compliance date to March 1, 2016. FDA notes that the compliance policy does not extend to other requirements of the Federal Food, Drug, and Cosmetic Act, including those in section 582, such as verification related to suspect and illegitimate product (including quarantine, investigation, notification and recordkeeping) and requirements related to engaging in transactions only with authorized trading partners.
The guidance document is available on the
Source:
Articles in this issue
almost 10 years ago
New Reagents and Reactions Advance Fluorination Chemistryalmost 10 years ago
CMOs Ride Continuing Strength of Small-Molecule Drug Sectoralmost 10 years ago
Lubrizol Introduces Topical Filmalmost 10 years ago
Ashland Presents Scientific Studies for Drug Formulationalmost 10 years ago
Xcelience Opens New Headquartersabout 10 years ago
Catalent Expands Cold-Chain Capacity at Shanghai Facilityabout 10 years ago
Croda's French Facility Receives EXCiPACT Certificationabout 10 years ago
Capsugel Launches enTRinsic Drug Delivery Technology Platformabout 10 years ago
Rx-360 Names Mark Paxton as New CEONewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





